Literature DB >> 15655679

Effect of substrate feed rate on recombinant protein secretion, degradation and inclusion body formation in Escherichia coli.

Maria Boström1, Katrin Markland, Anna Maria Sandén, My Hedhammar, Sophia Hober, Gen Larsson.   

Abstract

The effect of changes in substrate feed rate during fedbatch cultivation was investigated with respect to soluble protein formation and transport of product to the periplasm in Escherichia coli. Production was transcribed from the P(malK) promoter; and the cytoplasmic part of the production was compared with production from the P(lacUV5) promoter. The fusion protein product, Zb-MalE, was at all times accumulated in the soluble protein fraction except during high-feed-rate production in the cytoplasm. This was due to a substantial degree of proteolysis in all production systems, as shown by the degradation pattern of the product. The product was also further subjected to inclusion body formation. Production in the periplasm resulted in accumulation of the full-length protein; and this production system led to a cellular physiology where the stringent response could be avoided. Furthermore, the secretion could be used to abort the diauxic growth phase resulting from use of the P(malK) promoter. At high feed rate, the accumulation of acetic acid, due to overflow metabolism, could furthermore be completely avoided.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655679     DOI: 10.1007/s00253-004-1855-4

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  2 in total

1.  Suppressing glucose uptake and acetic acid production increases membrane protein overexpression in Escherichia coli.

Authors:  Emma Bäcklund; Marina Ignatushchenko; Gen Larsson
Journal:  Microb Cell Fact       Date:  2011-05-17       Impact factor: 5.328

2.  Boosting Recombinant Inclusion Body Production-From Classical Fed-Batch Approach to Continuous Cultivation.

Authors:  Julian Kopp; Anna-Maria Kolkmann; Patrick Gwen Veleenturf; Oliver Spadiut; Christoph Herwig; Christoph Slouka
Journal:  Front Bioeng Biotechnol       Date:  2019-10-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.